A rapid single-step gradient method for the generation of nanobodies against emergent diseases such as SARS-COV2
Abstract
New and fast single-step gradient method for quickly generating nanobodies against any antigen, incluing emerging diseases such as SARS-CoV2. The invention also provides a set of nanobodies against SARS-CoV2 and their use to detect and neutralize the virus (SEQ ID No. 1 to 56).
Más información
| Fecha de publicación: | 2020 |
| Idioma: | Nanobodies; gradient; method |
| DOI: |
Patent application in process. |
| Notas: | Patent application filed on May 15, 2020. EFS ID: 39455610 Application number: 63025534 Confirmation number: 6172 Attorney docket number: 20898.0006USP1 |